Recent Videos
INTERPHEX 2025: Continuous and Controlled Freeze-DryingBehind the Headlines Episode 14–Investment Trends, Policy Realignments, and VaccinesINTERPHEX 2025: AI and Automation in PharmaINTERPHEX 2025: Automation for Protein ManufacturingIndustry Outlook 2025: Political Impacts on Supply ChainsIndustry Outlook 2025: Business Viability and Global CollaborationIndustry Outlook 2025: Large Language ModelsDrug Digest: Strategic Partnerships Behind the Headlines: Episode 13; Budget Cuts, Reshoring, and Biotech Buyouts Industry Outlook 2025: Continuing Innovation
Related Content
PharmTech News
|
Business News
|
Latest Conference
|
Manufacturing
|
Manufacturing, Parenterals and Injectables
|
Manufacturing, Biosimilars and Biobetters
|
Manufacturing, Inhalation Drugs
|
Manufacturing, Solid and Semi-Solid Dosage Drugs
|
Contract Manufacturing, General
|
Outsourcing
|
Manufacturing, Cell Therapies
|
Manufacturing, Biologic Drugs
|
Manufacturing, Gene Therapies
|
INTERPHEX
INTERPHEX 2025: Industry Initiates Interchangeable Single-Use Assembly Components in Response to COVID-19 Supply-Chain Disruption
Patrick Lavery;Feliza Mirasol
April 3rd 2025ArticleSitting down with the PharmTech Group at INTERPHEX 2025, Nicole Hunter, head of Global WMArchitect at WMFTS, explains the industry initiative around single-use assembly components resulting from supply disruptions caused by the COVID-19 pandemic.
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
Felicity Thomas
June 25th 2024PodcastIn this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
Susan J. Schniepp;Rona LeBlanc-Rivera, PhD
April 2nd 2025ArticleSusan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
Feliza Mirasol
April 30th 2024PodcastIn this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Martin A. Makary Becomes New FDA Commissioner
Susan Haigney
April 2nd 2025ArticleMartin A. Makary, confirmed by a bipartisan vote of the US Senate, has been sworn in as FDA’s new commissioner.
INTERPHEX 2025: How Functional Labeling Can Protect Parentals in Vials and Syringes
Patrick Lavery;Feliza Mirasol
April 1st 2025ArticleWilliam Wainwright, business development manager at Iwata Label USA, discusses the practical security benefits of functional labels at INTERPHEX 2025.